These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31176566)

  • 1. Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
    Sun H; Shah P; Nguyen K; Yu KR; Kerns E; Kabir M; Wang Y; Xu X
    Bioorg Med Chem; 2019 Jul; 27(14):3110-3114. PubMed ID: 31176566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly predictive and interpretable models for PAMPA permeability.
    Sun H; Nguyen K; Kerns E; Yan Z; Yu KR; Shah P; Jadhav A; Xu X
    Bioorg Med Chem; 2017 Feb; 25(3):1266-1276. PubMed ID: 28082071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A consistent dataset of kinetic solubilities for early-phase drug discovery.
    Kramer C; Heinisch T; Fligge T; Beck B; Clark T
    ChemMedChem; 2009 Sep; 4(9):1529-36. PubMed ID: 19588473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.
    Cheng A; Merz KM
    J Med Chem; 2003 Aug; 46(17):3572-80. PubMed ID: 12904062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of aqueous solubility of crystalline un-ionized organic chemicals and drugs based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigor'ev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    J Chem Inf Model; 2014 Feb; 54(2):683-91. PubMed ID: 24456022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive models for estimating cytotoxicity on the basis of chemical structures.
    Sun H; Wang Y; Cheff DM; Hall MD; Shen M
    Bioorg Med Chem; 2020 May; 28(10):115422. PubMed ID: 32234277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on prediction of the aqueous solubility using the general solubility equation (GSE) versus a genetic algorithm and a support vector machine model.
    Alantary D; Yalkowsky S
    Pharm Dev Technol; 2018 Sep; 23(7):739-740. PubMed ID: 28425310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous solubility prediction: do crystal lattice interactions help?
    Salahinejad M; Le TC; Winkler DA
    Mol Pharm; 2013 Jul; 10(7):2757-66. PubMed ID: 23718811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational aqueous solubility prediction for drug-like compounds in congeneric series.
    Du-Cuny L; Huwyler J; Wiese M; Kansy M
    Eur J Med Chem; 2008 Mar; 43(3):501-12. PubMed ID: 17574307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Straightforward recursive partitioning model for discarding insoluble compounds in the drug discovery process.
    Lamanna C; Bellini M; Padova A; Westerberg G; Maccari L
    J Med Chem; 2008 May; 51(10):2891-7. PubMed ID: 18419111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and nonlinear functions on modeling of aqueous solubility of organic compounds by two structure representation methods.
    Yan A; Gasteiger J; Krug M; Anzali S
    J Comput Aided Mol Des; 2004 Feb; 18(2):75-87. PubMed ID: 15287695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances on aqueous solubility prediction.
    Wang J; Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):328-38. PubMed ID: 21470182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
    Poulin P; Jones HM; Jones RD; Yates JW; Gibson CR; Chien JY; Ring BJ; Adkison KK; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Ku MS
    J Pharm Sci; 2011 Oct; 100(10):4050-73. PubMed ID: 21523782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSPR studies on aqueous solubilities of drug-like compounds.
    Duchowicz PR; Castro EA
    Int J Mol Sci; 2009 Jun; 10(6):2558-2577. PubMed ID: 19582218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating ADME QSAR Models Using Marketed Drugs.
    Siramshetty V; Williams J; Nguyễn ÐT; Neyra J; Southall N; Mathé E; Xu X; Shah P
    SLAS Discov; 2021 Dec; 26(10):1326-1336. PubMed ID: 34176369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.
    Sutherland JJ; Raymond JW; Stevens JL; Baker TK; Watson DE
    J Med Chem; 2012 Jul; 55(14):6455-66. PubMed ID: 22716080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species.
    Wuelfing WP; Daublain P; Kesisoglou F; Templeton A; McGregor C
    Mol Pharm; 2015 Apr; 12(4):1031-9. PubMed ID: 25671350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.